Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.

Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.

Item
http://www.wikidata.org/entity/Q38392764
Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach.Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion.Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells: IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASEAssociation of muscle lipidomic profile with high-fat diet-induced insulin resistance across five mouse strains.Brain Ceramide Metabolism in the Control of Energy Balance.What Is Lipotoxicity?The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.[Sphingosine kinase-1: role in non alcoholic fatty liver disease].
P2860

Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.

Item
http://www.wikidata.org/entity/Q38392764
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
@en
type
label
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
@en
prefLabel
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
@en
P2093
P2860
P304
P31
P356
10.1517/14728222.2015.1028359
P407
P433
P478
P50
P577
P5875
P698
P921